GEMMA Biotherapeutic Announces Clinical Trial Authorization for New Gene Therapy Treatment
GEMMA announced that its novel gene therapy for spinal muscular atrophy type 1 (SMA1) has been cleared for clinical trial in Brazil.
Solid Biosciences Doses First Participant in First-in-Class Clinical Trial Evaluating Gene Therapy for the Treatment of Friedreich’s Ataxia
Initial trial data is expected in the second half of 2026.
Osetomics Appoints Global Medical Device Leader as CEO
The company is currently raising $8.5 million to support further development of its diagnostic and prognostic tools.
Vasowatch Receives $150K from Ben Franklin University Partners
Vasowatch received $150K from Ben Franklin Technology Partners.
Linnaeus Therapeutics Awarded Up to $22 Million from ARPA-H to Advance its Lead Drug Candidate for Healthspan Preservation
Linnaeus will use these funds to further develop LNS880.
Washington Post Article Highlights Bayh-Dole’s Role in U.S. Innovation
The article discusses how nearly all significant modern medicines originated from taxpayer-funded university research.
Eli Lilly Announces Opening of Lilly Gateway Labs Site in Philadelphia
The facility, which will support six to eight biotech startups, is set to open next year.
Penn Leaders Share Penn’s Approach to the Rapidly Changing Research Landscape
The article details Penn’s focus on sustaining research excellence, strengthening collaboration, and reshaping the University’s research enterprise to further expand its impact.
Penn Expands its Immunology Research
Penn’s newly developed seven-story facility at 3600 Civic Center Boulevard will bring together labs across disciplines to advance breakthroughs in immune health, autoimmunity, and infectious diseases.
Penn Signs Cooperative AI Advising Agreement with the Commonwealth of Pennsylvania
The University of Pennsylvania and Pennsylvania Governor Josh Shapiro’s Office of Administration signed a cooperative agreement.